These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12709427)

  • 1. Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms.
    Lloyd-Evans E; Pelled D; Riebeling C; Bodennec J; de-Morgan A; Waller H; Schiffmann R; Futerman AH
    J Biol Chem; 2003 Jun; 278(26):23594-9. PubMed ID: 12709427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms.
    Lloyd-Evans E; Pelled D; Riebeling C; Futerman AH
    Biochem J; 2003 Nov; 375(Pt 3):561-5. PubMed ID: 12917012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced calcium release in the acute neuronopathic form of Gaucher disease.
    Pelled D; Trajkovic-Bodennec S; Lloyd-Evans E; Sidransky E; Schiffmann R; Futerman AH
    Neurobiol Dis; 2005 Feb; 18(1):83-8. PubMed ID: 15649698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease.
    Nilsson O; Svennerholm L
    J Neurochem; 1982 Sep; 39(3):709-18. PubMed ID: 7097276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
    Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
    FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosphingomyelin-elicited Ca2+ mobilization from rat brain microsomes.
    Furuya S; Kurono S; Hirabayashi Y
    J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):303-11. PubMed ID: 8906576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of ryanodine receptors in sphingosylphosphorylcholine-induced calcium release from brain microsomes.
    Dettbarn C; Betto R; Salviati G; Sabbadini R; Palade P
    Brain Res; 1995 Jan; 669(1):79-85. PubMed ID: 7712168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease.
    Hamler R; Brignol N; Clark SW; Morrison S; Dungan LB; Chang HH; Khanna R; Frascella M; Valenzano KJ; Benjamin ER; Boyd RE
    Anal Chem; 2017 Aug; 89(16):8288-8295. PubMed ID: 28686011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3.
    Schueler UH; Kolter T; Kaneski CR; Blusztajn JK; Herkenham M; Sandhoff K; Brady RO
    Neurobiol Dis; 2003 Dec; 14(3):595-601. PubMed ID: 14678774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons.
    Korkotian E; Schwarz A; Pelled D; Schwarzmann G; Segal M; Futerman AH
    J Biol Chem; 1999 Jul; 274(31):21673-8. PubMed ID: 10419477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.
    Meivar-Levy I; Horowitz M; Futerman AH
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):377-82. PubMed ID: 7980395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid derivatives modulate intracellular Ca2+ in rat synaptosomes.
    Miguel BG; Calcerrada MC; Catalán RE; Martínez AM
    Acta Neurobiol Exp (Wars); 2001; 61(2):113-7. PubMed ID: 11512408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C.
    Abe A; Wu D; Shayman JA; Radin NS
    Eur J Biochem; 1992 Dec; 210(3):765-73. PubMed ID: 1483461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride.
    Bodennec J; Trajkovic-Bodennec S; Futerman AH
    J Lipid Res; 2003 Jul; 44(7):1413-9. PubMed ID: 12730305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sphingosine derivatives on MC3T3-E1 pre-osteoblasts: psychosine elicits release of calcium from intracellualr stores.
    Liu R; Farach-Carson MC; Karin NJ
    Biochem Biophys Res Commun; 1995 Sep; 214(2):676-84. PubMed ID: 7677781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration.
    Farfel-Becker T; Vitner EB; Kelly SL; Bame JR; Duan J; Shinder V; Merrill AH; Dobrenis K; Futerman AH
    Hum Mol Genet; 2014 Feb; 23(4):843-54. PubMed ID: 24064337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.
    Orvisky E; Park JK; LaMarca ME; Ginns EI; Martin BM; Tayebi N; Sidransky E
    Mol Genet Metab; 2002 Aug; 76(4):262-70. PubMed ID: 12208131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants.
    Nilsson O; Grabowski GA; Ludman MD; Desnick RJ; Svennerholm L
    Clin Genet; 1985 May; 27(5):443-50. PubMed ID: 3924448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosylceramide and related compounds in normal tissues and in Gaucher disease.
    Suzuki K
    Prog Clin Biol Res; 1982; 95():219-30. PubMed ID: 7122635
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucosylceramide modulates membrane traffic along the endocytic pathway.
    Sillence DJ; Puri V; Marks DL; Butters TD; Dwek RA; Pagano RE; Platt FM
    J Lipid Res; 2002 Nov; 43(11):1837-45. PubMed ID: 12401882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.